Study Shows Remdesivir, Gilead’s Fast-Tracked Coronavirus Treatment Drug, Fails To Mitigate Deaths

A new study out Thursday shows remdesivir, the only antiviral therapeutic approved for treatment of the novel Wuhan coronavirus, does not prevent deaths in COVID-19-infected patients. The study, conducted by the World Health Organization (WHO) tracked more than 11,300 adults across 30 different countries to examine the mortality rate benefits of the drug manufactured by Gilead. President Donald Trump was

Continue Reading Study Shows Remdesivir, Gilead’s Fast-Tracked Coronavirus Treatment Drug, Fails To Mitigate Deaths